CV Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
CV Sciences, Inc. (CVSI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.04 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-13
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $0.04, a 33.33% increase year-over-year.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-03-31 was $0.03.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-06-30 was $0.05, a 25.00% increase year-over-year.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-06-30 was $0.04.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $0.03, a 40.00% decline from fiscal 2024.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $0.05, a 25.00% increase from fiscal 2023.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $0.04, a 33.33% increase from fiscal 2022.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $0.03, a 93.75% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.04 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $0.04 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $0.03 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $0.03 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.03 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | $0.03 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $0.05 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $0.05 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $0.05 10-Q · filed 2025-08-13 | $0.05 10-Q · filed 2025-08-13 | ||
| 2023-12-31 | $0.04 10-K · filed 2025-03-27 | |||
| 2023-09-30 | $0.04 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $0.04 10-Q · filed 2024-08-13 | $0.04 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $0.04 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $0.03 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $0.03 10-Q · filed 2023-11-14 | $0.03 10-Q · filed 2023-11-14 | ||
| 2021-12-31 | $0.48 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $0.49 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $0.32 10-Q · filed 2022-08-15 | $0.49 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.53 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $0.36 10-K · filed 2022-04-04 | |||
| 2020-09-30 | $0.47 10-Q · filed 2021-11-15 | $0.36 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.61 10-Q · filed 2021-08-16 | $0.36 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.29 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $1.92 10-K · filed 2021-03-19 | |||
| 2019-09-30 | $3.16 10-Q · filed 2020-11-06 | $3.83 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $3.31 10-Q · filed 2020-08-07 | $4.00 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $4.03 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $0.72 10-K · filed 2020-03-30 | |||
| 2018-09-30 | $3.08 10-Q · filed 2019-11-06 | $0.54 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.30 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $0.30 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $0.15 10-K · filed 2019-03-12 |